Association of apolipoprotein B and lipoprotein(a) with severe atherosclerotic cardiovascular disease in patients with acute coronary syndrome: the modifying effect of prior lipid-lowering therapy.
The interplay between apolipoprotein B (apoB) and Lipoprotein(a) [Lp(a)] in determining atherosclerotic cardiovascular disease (ASCVD) severity remains complex, particularly under the influence of lipid-lowering therapy (LLT). To evaluate the association of apoB and Lp(a) with severe ASCVD in patients hosp...